Cxbladder Triage

Cxbladder Triage is a laboratory test designed for the evaluation of hematuria, helping you rule out the presence of bladder cancer quickly, easily and painlessly. Cxbladder Triage is particularly suitable for low-risk patients such as those with microhematuria, younger patients and non-smokers or those who may not tolerate cystoscopy for medical or religious reasons.

Rule out cancer quickly with confidence

Cxbladder Triage is an accurate, non-invasive test with high NPV (98.5%) and high sensitivity (95.1%). This helps you to confidently and easily rule out bladder cancer at the start of the diagnostic pathway for patients presenting with hematuria.¹

Cutting edge diagnostics

Combining known bladder cancer risk factors with state of the art molecular diagnostics, Cxbladder Triage uses genomic and clinical information to calculate a segregation index that can help rule out bladder cancer. This innovative approach to urological diagnostics is the first test of its kind in this market.

Clinical applications

• Replaces other urine-based tests in primary workup
• Triage low-risk patients such as those with microhematuria for whom a more extensive evaluation may not be required
• Provide patients with the peace of mind that they have a low probability of bladder cancer
• Identify patients who require a Standard Clinical Workup
• Evaluate patients in 'at-risk' populations 

Other benefits

• Only a small sample of urine is needed and refrigeration is not required
• Our qualified laboratory will return you the test results within seven working days from receipt of sample

• References

  ¹ Kavalieris et al: A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma. BMC Urology 2015; 15:23 Read article